93 7219 Pill — YELLOW OVAL, 14mm — Topiramate

Imprint	93 / 7219
Colour	YELLOW
Shape	OVAL
Size	14
Strength	TOPIRAMATE 100 mg
Dosage form	Tablet
Manufacturer	Teva Pharmaceuticals USA, Inc.
NDC	0093-7219
Schedule	—
Availability	—
Ingredients	TOPIRAMATE[TOPIRAMATE]

What does this imprint mean?

The imprint "93 7219" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Topiramate

Uses and warnings

No boxed warning; contraindications are listed as "none." Major warnings include "acute myopia and secondary angle closure glaucoma," which can cause "permanent vision loss" if untreated; "fetal toxicity," as use "during pregnancy can cause cleft lip and/or cleft palate"; "metabolic acidosis" from decreased serum bicarbonate, which can be severe; the class-wide warning that "antiepileptic drugs increase the risk of suicidal thoughts or behavior"; and "oligohidrosis and hyperthermia," primarily reported in pediatric patients, requiring monitoring for decreased sweating and elevated body temperature.

Topiramate tablets are indicated for: - "Initial monotherapy" in patients ≥2 years with partial-onset or primary generalized tonic-clonic seizures - "Adjunctive therapy" in adults and pediatric patients 2-16 years with partial-onset seizures, primary generalized tonic-clonic seizures, or seizures associated with Lennox-Gastaut syndrome - "Prophylaxis of migraine headache" in adults

Read the full drug profile →